James Muse
Optometrist · Clearwater, FLNPI 1710964077
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,105 of the $5,932 with a category attached, or 86.1%. 18 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 34.2% of the total. Reporting peaked in 2019 at $1,439 and has fallen 70.7% since, to $421 in 2025. Among optometrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $52.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Alcon$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$805
- AbbVie$354
- Oyster Point Pharma, Inc.$318
- Sun Pharmaceutical Industries Inc.$177
- plus $576 from 12 others
What the payments were for
- Travel & lodging$82714%
- Food & beverage$5,10586%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 22 | $2,031 |
| Alcon | 26 | $1,671 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 23 | $805 |
| AbbVie(2 entities) | 12 | $354 |
| Oyster Point Pharma, Inc. | 6 | $318 |
| Sun Pharmaceutical Industries Inc. | 4 | $177 |
| Dompe US, Inc. | 2 | $141 |
| Sight Sciences, Inc. | 1 | $105 |
| Aerie Pharmaceuticals, Inc. | 4 | $72 |
| Kala Pharmaceuticals, Inc. | 4 | $61 |
| Genmab U.S., Inc. | 2 | $41 |
| Novartis | 2 | $31 |
| Rayner Intraocular Lenses Limited | 1 | $27 |
| Coopervision Inc. | 1 | $24 |
| Johnson & Johnson Vision Care, Inc. | 1 | $23 |
| ABB Con-cise Optical Group LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,932 in reported general payments places this provider in the 90th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 36 | $1,044 |
| Prednisolone Acetate | 15 | $402 |
| Latanoprost | 28 | $361 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $190 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Clearwater
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
- Robert DavisPembroke Pines$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.